F-16615

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameF-16615

Drug Alias Namepartial 5HT1A agonist (Pierre Fabre)dual D2/5HT2B antagonist/partial 5HT1A agonist (Pierre Fabre)dual D2/5HT2B antagonist (Pierre Fabre)F-16615

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSerotonin 1a (5-HT1a) receptor partial agonistsDopamine D2 receptor antagonistsSerotonin 2b (5-HT2b) receptor antagonists

TargetsSerotonin 2b (5-HT2b) receptorSerotonin 1a (5-HT1a) receptorDopamine D2 receptor

Therapy Area/IndicationsPsychotic Disorders

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryEurope

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPierre Fabre Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesPierre Fabre Ltd

Active IndicationsN/A

Inactive IndicationsPsychotic Disorders

Other Information

ATC CodeN/A